1
2
3
Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.M.H., Teeuwen, N.J.A., Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
4
Seferina, S.C., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., van den Berkmortel, F., van Kampen, R.J.W., van de Wouw, A.J., de Vries, B., Joore, M.A., Peer, P.G.M., Voogd, A.C., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
5
Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A.C., Dercksen, M.W., van den Berkmortel, F., Smilde, T.J., van de Wouw, A.J., Peters, F.P.J., van Riel, J.M.G.H., Peters, N.A.J.B., de Boer, M., Peer, P.G.M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Annals of Oncology ; volume 27, issue 2, page 256-262 ; ISSN 0923-7534;
2016
Veröffentlicht in: Annals of Oncology ; volume 27, issue 2, page 256-262 ; ISSN 0923-7534;
2016